Tackling the elective case backlog generated by Covid-19: the scale of the problem and solutions

Abstract

Background In April 2020, Covid-19 brought NHS elective procedures to a halt. The aim of this paper is to produce accurate forecasts on the building backlog, highlight the state of waiting lists currently and propose solutions required to prevent a public health crisis. Method Using data published by NHS digital and NHS England on previous years, we have analysed and used this to produce estimates of cancellations and missed cases. We also analyse government data on waiting lists and show compliance or lack of with these. Results We show that compliance with waiting list times pre pandemic was falling year on year (83.2% in 2020 down from 87% in 2019). Every month that passes we estimate that 400 000 cases are not being performed. This may include urgent cancer care work in some trusts. Conclusions Waiting lists have been governed by strict rules since 2004. Given falling compliance with 18-week intention to treat we believe the scale of the backlog combined with NHS capacity diminished due to Covid-19 precautions is a public health crisis waiting to occur. We identify difficulties in resuming elective work and suggest strategies that could be employed to avoid a public health crisis.

Percutaneous Achilles tenotomy under local anaesthetic in the clubfoot clinic was safe during the COVID-19 pandemic, for both children and parents

“…The COVID-19 pandemic has had unprecedented adverse consequences on healthcare in the UK. Paediatric surgery was specifically impacted by a drastic reduction of operating availability and consequently resulted in a significant backlog [ 23 , 24 ]. Whilst it was recognised that there would be an impact on the functional outcome of CTEV patients by delays in treatment, national and local protocols were implemented to place a hold on their treatment [ 24 , 25 ].…”

Reducing waiting lists for laparoscopic cholecystectomy: An intensive approach to aid COVID-19 recovery

“…As intensive work is done to aid recovery and prioritise cancer work, elective benign surgery continues to struggle to get back to full speed even a year down the line. In November 2019 there were 4.5 million patients waiting for elective treatment on the NHS, with an estimate of an additional 1.2 million every 3 months of the pandemic being added to that [ 7 ]. With the impending waiting list crisis and continued burden on the healthcare service due to COVID-19 there has been much debate as to the best strategy to tackle elective surgery moving forward in both an effective and timely manner.…”

Postponing elective surgery due to COVID-19 did not decrease the oncological surgery rate in Finland

“…Health officials warned that cancelled elective visits would cause a backlog that could take years to clear 2 . In Finland, costs of these cancellations have been estimated at €2 billion, along with up to 3 million cancelled secondary-care visits in a population of 5.5 million 3 .…”